Table 1.
Demographic Information and Complementary and Alternative Medicine Use
| |
|
CAM use |
No CAM use |
|
||
|---|---|---|---|---|---|---|
| N (%) | N | % | N | % | p-Value | |
| Total | 316 | 193 | 61.3 | 122 | 38.7 | |
| Age, years | 0.118 | |||||
| ≤65 | 220 (69.6) | 141 | 64.1 | 79 | 35.9 | |
| >65 | 96 (30.4) | 52 | 54.7 | 43 | 45.3 | |
| Gender | 0.005 | |||||
| Male | 112 (35.4) | 57 | 50.9 | 55 | 49.1 | |
| Female | 204 (64.6) | 136 | 67.0 | 67 | 33.0 | |
| Race/ethnicity | 0.636 | |||||
| White | 243 (76.9) | 150 | 62.0 | 92 | 38.0 | |
| Nonwhite* | 73 (23.1) | 43 | 58.9 | 30 | 41.1 | |
| Educational Level | 0.093 | |||||
| High school or less | 87 (27.7) | 46 | 53.5 | 40 | 46.5 | |
| College or above | 227 (72.3) | 145 | 63.9 | 82 | 36.1 | |
| Employment | 0.776 | |||||
| Not employed | 175 (56.3) | 106 | 60.9 | 68 | 39.1 | |
| Employed | 136 (43.7) | 85 | 62.5 | 51 | 37.5 | |
| Cancer Type | 0.016 | |||||
| Breast | 90 (28.6) | 65 | 72.2 | 25 | 27.8 | |
| GI | 86 (27.3) | 48 | 55.8 | 38 | 44.2 | |
| Lung | 98 (31.1) | 51 | 52.6 | 46 | 47.4 | |
| Other | 41 (13.0) | 29 | 61.5 | 12 | 29.3 | |
| Cancer Stage | 0.957 | |||||
| Localized disease | 146 (46.6) | 89 | 61.4 | 56 | 38.6 | |
| Metastatic disease | 167 (53.4) | 103 | 61.7 | 64 | 38.3 | |
| Surgery | 0.043 | |||||
| No | 142 (45.1) | 78 | 55.3 | 63 | 44.7 | |
| Yes | 173 (54.9) | 115 | 66.5 | 58 | 33.5 | |
| Radiation | 0.221 | |||||
| No | 168 (53.3) | 98 | 58.3 | 70 | 41.7 | |
| Yes | 147 (46.7) | 95 | 65.1 | 51 | 34.9 | |
| Chemotherapy | 0.738 | |||||
| No | 34 (10.8) | 20 | 58.8 | 14 | 41.2 | |
| Yes | 281 (89.2) | 173 | 61.8 | 107 | 38.2 | |
| Time since diagnosis | 0.018 | |||||
| ≤12 months | 141 (45.5) | 76 | 53.9 | 65 | 46.1 | |
| >12 and ≤36 months | 80 (25.8) | 58 | 72.5 | 22 | 27.5 | |
| >36 months | 89 (28.7) | 58 | 65.2 | 31 | 34.8 | |
P-values in boldface type are statistically significant.
*
Mostly African American.
CAM, complementary and alternative medicine.